FDA Approves Eyelash Drug

The FDA has approved the glaucoma drug bimatoprost for treating eyelash hypotrichosis, or lashes that are not long, thick, or dark enough. The drug will be marketed under the name "Latisse" and is applied to the base of the upper eyelashes. Growth increases can be seen within eight to 16 weeks, according to Allergan.

Assuming potential side effects are minor, would you try the drug?

Glaucoma Drug Enhances Eyelashes